Do oxidized LDL and F2-isoprostanes reflect oxidative lipid damage that activates macrophages and inflammatory signaling?

In aging individuals, assessing subclinical vascular risk requires sensitive biomarkers that reflect active, localized, and systemic pathological processes. Oxidized low-density lipoprotein (oxLDL) and F2-isoprostanes serve as robust, complementary indicators of oxidative lipid damage that directly initiate and sustain vascular inflammation.

Biomarkers of oxidative damage

• Systemic vs. localized peroxidation: F2-isoprostanes are stable, non-enzymatically generated prostaglandin-like compounds formed during the free radical-mediated peroxidation of arachidonic acid. They serve as the gold-standard biomarker for systemic lipid peroxidation. In contrast, oxLDL specifically reflects localized, peroxynitrite-mediated oxidative modification of lipoproteins within the vascular microenvironment.

Mechanistic pathways of macrophage activation

• Receptor-mediated signaling: oxLDL binds to scavenger receptors CD36 and LOX-1, forming signaling complexes with TLR4/6 heterodimers. This cascade activates downstream JNK and NF-κB pathways, driving transcription of pro-inflammatory cytokines. Meanwhile, F2-isoprostanes (such as 8-iso-PGF2α) bind to the G-protein-coupled thromboxane A2 receptor (TXA2R), phosphorylating ERK1/2 and p38 MAPK to upregulate IL-8 and promote a foam-cell phenotype.
• Feed-forward amplification: The internalization of oxLDL by macrophages triggers intracellular reactive oxygen species (ROS) production. This increased oxidative stress drives the non-enzymatic peroxidation of cellular arachidonic acid, yielding endogenous F2-isoprostanes and establishing a self-amplifying cycle of oxidative damage.
• Downstream chronic signaling: Receptor-mediated activation primes the NLRP3 inflammasome. Downstream assembly and caspase-1 activation drive the maturation and sustained release of highly inflammatory cytokines (IL-1β, IL-18, TNF-α, and IL-6) and chemokines (MCP-1), recruiting additional monocytes and perpetuating chronic vascular remodeling.

Bottom line

• Oxidized LDL and F2-isoprostanes are active biological mediators of vascular disease that trigger a feed-forward loop of macrophage activation, NF-κB signaling, and NLRP3 inflammasome upregulation, leading to chronic, self-perpetuating vascular inflammation.